2656400-84-7
Chemical Structure
THR-β agonist 3
- CAS. Nr.: 2656400-84-7
- Formula:C29H32ClO5P
- Molecular Weight:526.99
IUPAC Name: (2R,4S)-4-(3-chlorophenyl)-2-((((R)-1-(4-hydroxy-3-isopropylphenyl)-7-methyl-2,3-dihydro-1H-inden-5-yl)oxy)methyl)-1,3,2-dioxaphosphinane 2-oxide
InChIKey: WZCDYBOIHFQXJO-OJMOVJAGSA-N
SMILES: CC1=C2[C@](C3=CC(C(C)C)=C(C=C3)O)([H])CCC2=CC(OC[P@@]4(O[C@@](C5=CC(Cl)=CC=C5)([H])CCO4)=O)=C1
Biological Activity: THR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6)[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
THR-β agonist 3 | THR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
